NCT04244201 (VHT1) is a NA clinical trial of Vaporous Hyperoxia Therapy in Neuropathic Foot Ulcer, sponsored by Vaporox.

Who is sponsoring NCT04244201?

NCT04244201 is sponsored by Vaporox.

What drugs are being tested in NCT04244201?

Interventions in NCT04244201: Vaporous Hyperoxia Therapy.

What condition does NCT04244201 study?

NCT04244201 studies Neuropathic Foot Ulcer, Foot Ulcer.

Is NCT04244201 still recruiting?

NCT04244201 is currently completed. Last updated 30 January 2020.

Last reviewed 2020-01-30 · How we verify

NCT04244201: VHT1

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Vaporous Hyperoxia Therapy (VHT) in the Treatment of Foot Wounds

Completed NA Last updated 30 January 2020

What this trial tests

NA trial testing Vaporous Hyperoxia Therapy in Neuropathic Foot Ulcer in 31 participants. Completed in 4 October 2007.

Timeline

6 June 2005

Primary endpoint
1 March 2007

4 October 2007

Quick facts

Lead sponsor	Vaporox
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	31
Start date	6 June 2005
Primary completion	1 March 2007
Estimated completion	4 October 2007

Drugs / interventions tested

Vaporous Hyperoxia Therapy

Conditions studied

Neuropathic Foot Ulcer — all drugs for Neuropathic Foot Ulcer →
Foot Ulcer — all drugs for Foot Ulcer →

Sponsor

Vaporox

Who can join

18 and older, any sex, with Neuropathic Foot Ulcer or Foot Ulcer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate the effectiveness of Vaporous Hyperoxia Therapy (VHT), previously named Misty (WTS-1000) for the treatment of chronic foot ulcers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Vaporous Hyperoxia Therapy

Trials testing the same drug.

NCT04210609 — Effectiveness of Vaporous Hyperoxia Therapy (VHT) in the Treatment of Chronic Diabetic Foot Ulcers · NA · unknown

Other Vaporox trials

Trials by the same sponsor.

NCT04210609 — Effectiveness of Vaporous Hyperoxia Therapy (VHT) in the Treatment of Chronic Diabetic Foot Ulcers · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04244201 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Vaporox
Last refreshed: 30 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04244201.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing